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Catherine. Ledent@ulb We performed a longitudinal self-control chronic study, in which different outcomes could be 160 measured in the same animals. Therefore, after measuring the airway responsiveness at the 161 end of each month, the BAL was performed very carefully one day later under anaesthesia. 162
Then the lungs were excised, the left half was immediately fast frozen in liquid nitrogen for 163 cytokine and myeloperoxidase (MPO) measurement, the other half was put into formalin for 164 histological processing. The advantage of this technique is that we have all information from 165 the same mouse for better comparison and correlation, as well as help to keep the 3R 166 regulations from the animal ethical point of view (15) . 167
168
Determination of cannabinoid concentrations in the inhaled smoke with HPLC 169
The HPLC system consisted of a Dionex P680 gradient pump (Dionex Corp., Sunnyvale, CA, 170 USA), a helium degassing system, a Rheodyne 8125 injector valve with a 20μL loop 171 (Rheodyne Europe GmbH, Bensheim, Germany), and a Dionex 340D UV-vis diode array 172 detector (Dionex Corp., Sunnyvale, CA, USA). The eluate was monitored at ambient 173 temperature at range of 200 to 500 nm by DAD. The concentrations were calculated by using 174 wavelenghts where the investigated cannabinoids have their absorbance maximums. 175
Chromatographic separations were achieved using Intersil ODS-4 C18 reversed phase column 176 (3 μm, 2.1 mm x 150 mm i.d.). A Chromeleon data management software (Version 6.60 SP3 177
Build 1485, Dionex Corp., Sunnyvale, CA, USA) was used to control the equipment and for 178 data evaluation. The mobile phase consisted of a mixture of methanol/water containing 50 179 mM of ammonium formate (adjusted to pH 5.2). Initial setting was 75% methanol (v/v), 180 which was linearly increased to 90% methanol over 25 min, then increased to 100% in 1 min. 181
After maintaining this condition for 3 min, the column was set to initial condition in 1 min 182 8 and re-equilibrated under this condition for 6 min. The total runtime was 36 min. Flow rate 183 was set to 0.3 ml/min, the injection volume was 20 μl. All experiments were carried out at 184 
Statistical analysis 276
Results are expressed as means±SEM of n=6-8 mice in each group and evaluated by one-way 277 ANOVA followed by Bonferroni's modified t-test. In all cases p<0.05 was considered to be 278 significant. Evaluation of the semiquantitative histopathological scoring and inflammatory 279 cell count (n=30 counts/slides) was analysed by Kruskal-Wallis followed by Dunn's multiple 280 comparison test to observe intergroup differences at given timepoints. The mean linear 281 intercept length (n=80-100 measurements/slides) was analysed with two-way ANOVA 282 followed by Sidak's multiple comparison test. 283 284 285
RESULTS
287
The THC, cannabinol and cannabidiol concentrations of the inhaled smoke determined with 288 HPLC were 0.04 mg/ml, 0.02 mg/ml and 7.48x10 -4 mg/ml, which corresponded to 14.77%, 289 8.64% and 0.27% content of these components, respectively, per dry plant. The total 290 cannabinoid concentration of the urine was 56.6±5.4 ng/ml on day 5, and then remained 291 relatively stable from 57.1±4.3 ng/ml to 78.08±6.2 throughout the total 4-month-investigation 292 period. 293
294
Airway hyperreactivity 295
Airway responsiveness to the inhalation of the muscarinic receptor agonist carbachol 296 remarkably increased immediately after a week of marijuana smoke exposure, as shown by 297 the mean Penh curves (Fig. 1A) and also by the percentage Penh increase values above 298 baseline (Fig. 1E) . This remained relatively stable during the total duration of the 4-month-299 study. In contrast, tobacco smoke did not induce broncial hyperreactivity until the ninth week 300 of the experiment, but after this timepoint its action was similar to that of marijuana (Fig. 1A-301 
E). 302 303
Histopathological alterations in the lung 304
One month after the beginning of marijuana smoke exposure remarkable 305 perivascular/peribronchial edema (Figs. 2A, 6D) , neutrophil, lymphocyte and macrophage 306 infiltration (Figs. 2B, 6A-C, E), minimal epithelial irregularity (Figs. 2A, B, 6F ) and alveolar 307 space enlargement (Fig. 2C ) developed in the marijuana-exposed group. Most of these signs 308
were similar in tobacco-smoking mice, but edema formation was significantly increased only 309 13 in case of marijuana smoke exposure (Figs. 2D, 6D ) and there were significantly more 310 infiltrating granulocytes and lympocytes than in response to tobacco smoke (Fig. 6A, B) . 311
Two months of marijuana smoking induced vascular endothelial proliferation, definitive 312 inflammatory cell infiltration with significantly higher number of neutrophils as compared to 313 the tobacco smoke (Figs. 3A, 6A, E) , bronchial goblet cell hyperplasia (Fig. 3B, 6G) and 314 gradually increasing emphysema (Fig. 3C, 6I) . 315
Three months after starting the marijuana smoke exposure, massive interstitial neutrophil and 316 macrophage infiltration occured including multinucleated giant cells being significantly 317 greater than in case of tobacco-smoke, extensive lymphocyte accumulation around the vessels 318 and bronchi (Figs. 4A, B , 6A-C), significantly greater epithelial damage and hyperplasia of 319 goblet cells (Figs. 4C, 6F , G, I) could be seen. 320
Following 4 months of marijuana smoking, narrowed, obstructed, disintegrated and disrupted 321 bronchial epithelium with desquamated epithelial cells (Fig. 5A, 6F) , atelectasis, significantly 322 increased number of lymphocytes among cell debris in the scattered alveolar lumens, 323 microbleedings and remarkable fibrosis (Fig. 5B, 6H ) together with very severe emphysema 324 (Fig. 5C, 6I) were the characteristic histopathological alterations. In comparison, 4 months of 325 tobacco smoke induced significantly less severe interstitial inflammation (Fig. 6E) and 326 epithelian damage (Fig. 6F ), no fibrosis (Fig. 6H ) and milder emphysema (Fig. 5D, 6I) . 327 328 329
Inflammatory cell profile of the BALF 330
Inflammatory cells did not increase in the BALF after one month of either marijuana or 331 tobacco smoke exposure compared to the intact, non-smoking mice (Fig. 7A) . In contrast, 332 lymphocytes, granulocytes and macrophages significantly increased in both groups after 2 333 months (Fig. 7B) . The absolute number of all these inflammatory cells remarkably decreased 334 14 by the end of the third month. Lymphocytes and granulocytes remained significantly elevated 335 in the marijuana-smoking group, but the increase of only lymphocytes in the fourth month 336 was significant in response to tobacco (Fig. 7C, D) . 337 338 MPO activity in the lung homogenates 339 MPO activity, as a biochemical marker of neutrophil and macrophage accumulation, 340 significantly increased in the lung after one month of marijuana smoke exposure. It showed an 341 almost 5-fold elevation at the end of the second month, then it dramatically decreased, but still 342 remained significantly higher than that of the intact lung at the three-month timepoint. This 343 enzyme activity got back to the normal level after 4 months of marijuana smoking. In 344 contrast, in the lung of the tobacco-smoking group, the only remarkable, 3-fold MPO activity 345 elevation was observed at 2 months, but it proved to be significantly less than that measured 346 in marijuana-smoking animals (Fig.8A) . 347
348
Cytokine concentrations in the lung homogenates 349
At the 2-month timepoint where the intensity of the cellular inflammatory reaction showed its 350 maximum, the concentrations of four important inflammatory cytokines (MCP-1, IFN-γ, 351 TNF-α and IL-12), but interestingly also the anti-inflammatory IL-10, significantly increased 352 in the lung of tobacco-smoking animals compared to non-smoking ones. Furthermore, they 353 were significantly higher in the marijuana-smoking group than in the tobacco-smoking one. 354
Significant increase of the IL-6 level was only detected in marijuana-smoking mice (Fig. 8B) . Since the maximal inflammatory response was observed 2 months after the beginning of the 359 marijuana smoke exposure, the severity of the inflammation was investigated in CB1 -/-mice 360 compared to their wildtype CD1 controls at this timepoint. Pulmonary hyperreactivity to 361 inhaled carbachol developed similarly from the first week of marijuana smoking in both 362 groups (Fig. 9A) . The histopahological evaluation showed no significant difference either 363 between the massive perivascular/peribronchial edema and inflammatory cell accumulation, 364
or the moderate goblet cell hyperplasia in the bronchial epithelium and emphysema formation 365 in the two groups (Fig. 9B, C, D) . 366 367 368 DISCUSSION 369
In the present carefully designed comparative chronic experiment we provided several lines of 370 evidence that marijuana smoke is more harmful to the lungs than tobacco smoke. The obvious 371 advantage of using the cigarette smoke control group in our study is that it is the most 372 clinically relevant stimulus, which triggers inflammatory pathways leading to lung 373 destruction. The pathophysiological changes found in animal studies appear to be consistent 374 to that observed in man (23, 28). These are the first experimental data in a predictive mouse 375 model that marijuana smoke induces remarkable bronchial hyperresponsiveness very early, as 376 well as severe pulmonary inflammation, emphysema and tissue destruction, which are 377 independent of CB1 receptor activation. We proved with functional, morphological, 378 biochemical and immunological techniques that these characteristic pathophysiological 379 alterations are dependent on the duration of the smoke exposure. Airway hyperresponsiveness 380 was also detected after 2 months of tobacco smoke, but more severe hyperreactivity 381 developed in response to marijuana much earlier, 7 days after the first smoke inhalation. Since 382 remarkable inflammatory signs are not likely to develop at this timepoint, it is suggested that 383 16 marijuana smoke directly increases airway reactivity. Although in clinical reports direct short-384 term bronchodilation was described in response to marijuana primarily through CB1 receptor 385 activation in the lung (13), we clearly showed that after a longer period of time, it markedly 386 increases airway reactivity to muscarinic receptor activation in a CB1-independent manner. 387 Inflammation, as assessed by several histopathological parameters, such as 388 perivascular/peribronchial edema, neutrophil and macrophage infiltration, epithelial 389 irregularity and hyperplasia, atelectasia and emphysema, were also more severe and 390 developed earlier in the marijuana-exposed group than in tobacco-smoking mice. Vascular 391 endothelial proliferation, narrowed, obstructed and destructed bronchi with desquamated 392 epithelial cells, massive interstitial lympocyte infiltration, fibrosis and a remarkable loss of 393 the alveolar structure could be seen after four months of regular marijuana smoke exposure. 394
These severe morphological changes did not occur in response to tobacco smoke at this 395 timepoint. These results support the data of a controlled clinical study providing evidence for 396 a frequency-and duration dependent emphysema formation, focal alveolar edema, alveolar 397 and bronciolar destruction in regular marijuana smokers. The cell counts for granulocytes, 398 macrophages and lyphocytes in the BALF significantly and similarly increased at month 2 in 399 both the marijuana-and cigarette-smoking groups. This is explained by the histological 400
picture showing that at month 1 the massive edema, but not cell influx dominated the picture, 401 and the peribronchial/perivascular cellular inflammation peaked at the 2-month timepoint. At 402 the 3-and 4-month timepoints the BALF cell counts markedly decreased, which is explained 403 by the fact that inflammatory reaction decreases, it is localized to the lung parenchyma, and 404 the bronchiolar-alveolar structure becomes disrupted. Human investigations demonstrated that 405 there was no remarkable difference between the BALF cell counts in the marijuana smokers 406 and tobacco smokers, which also supports our similar, non-significant findings regarding the 407 BALF cell counts of marijuana-and cigarette-smoking mice (3). 408 MPO activity measured in the lung homogenates, which reflects to the number and function 409 of the accumulated granulocytes and macrophages in the parenchyma, significantly increased 410 after one month of marijuana smoke administration, but it showed an almost 5-fold elevation 411 at the end of the second month. It dramatically decreased, but still remained significantly 412 higher than that of the intact lung at the three-month timepoint. MPO activity got back to the 413 normal level after 4 months of marijuana smoking, which is explained by lymphocyte 414 dominance at this late timepoint. This explanation is well supported by the histopathological 415 picture. In contrast, in the lung of the tobacco-smoking group, the only remarkable (3-fold) 416 MPO activity elevation was observed at 2 months, but it proved to be significantly less than 417 that measured in marijuana-smoking animals. 418
The concentrations of four important inflammatory cytokines (MCP-1, IFN-γ, TNF-α and IL-419 12), but interestingly also the anti-inflammatory IL-10, were significantly higher in the lung 420 of marijuana-smoking animals compared to tobacco smoking ones at month 2 when the 421 inflammatory reaction reached its maximum. However, there was no difference in IL-6 levels, 422 which is predominantly secreted by T-cells and macrophages particularly in acute phase 423 reaction when fever is a major symptom, but not in chronic pulmonary inflammation. IL-10 424 (cytokine synthesis inhibitory factor) is synthesized by macrophages and lymphocytes, and it 425 decreases the production of several pro-inflammatory cytokines, such as IFN-γ and TNFα. Its 426 elevation can suggest an endogenous counter-regulatory mechanism for the inflammatory 427 reaction at the timepoint where the maximal inflammation develops. 
